• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性硬化性胆管炎引起的慢性胆汁淤积导致的肝适应性受损。

Impaired Hepatic Adaptation to Chronic Cholestasis induced by Primary Sclerosing Cholangitis.

机构信息

Department of Medical Biology, Pomeranian Medical University, Szczecin, Poland.

Endoscopy Unit, Ministry of Internal Affairs Hospital, Szczecin, Poland.

出版信息

Sci Rep. 2016 Dec 23;6:39573. doi: 10.1038/srep39573.

DOI:10.1038/srep39573
PMID:28008998
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5180097/
Abstract

Pathogenesis of primary sclerosing cholangitis (PSC) may involve impaired bile acid (BA) homeostasis. We analyzed expressions of factors mediating enterohepatic circulation of BA using ileal and colonic (ascending and sigmoid) biopsies obtained from patients with PSC with and without ulcerative colitis (UC) and explanted PSC livers. Two-fold increase of BA-activated farnesoid X receptor (FXR) protein levels were seen in ascending and sigmoid colon of PSC patients with correspondingly decreased apical sodium-dependent BA transporter (ASBT) gene expression. This was associated with increased OSTβ protein levels in each part of analyzed gut. An intestinal fibroblast growth factor (FGF19) protein expression was significantly enhanced in ascending colon. Despite increased hepatic nuclear receptors (FXR, CAR, SHP), and FGF19, neither CYP7A1 suppression nor CYP3A4 induction were observed. The lack of negative regulation of BA synthesis may be accountable for lower levels of cholesterol observed in PSC in comparison to primary biliary cholangitis (PBC). In conclusion, chronic cholestasis in PSC induces adaptive changes in expression of BA transporters and FXR in the intestine. However hepatic impairment of expected in chronic cholestasis downregulation of CYP7A1 and upregulation of CYP3A4 may promote BA-induced liver injury in PSC.

摘要

原发性硬化性胆管炎(PSC)的发病机制可能涉及胆汁酸(BA)稳态的受损。我们使用从患有 PSC 伴或不伴溃疡性结肠炎(UC)的患者和 PSC 肝移植中获得的回肠和结肠(升结肠和乙状结肠)活检组织分析了介导 BA 肠肝循环的因子的表达。在 PSC 患者的升结肠和乙状结肠中,BA 激活的法尼醇 X 受体(FXR)蛋白水平增加了两倍,相应的顶端钠依赖性 BA 转运蛋白(ASBT)基因表达减少。这与分析肠道各个部位的 OSTβ 蛋白水平增加有关。在升结肠中,肠成纤维细胞生长因子(FGF19)蛋白表达显著增强。尽管肝脏核受体(FXR、CAR、SHP)和 FGF19 增加,但未观察到 CYP7A1 抑制或 CYP3A4 诱导。与原发性胆汁性胆管炎(PBC)相比,PSC 中胆固醇水平较低可能是由于 BA 合成的负反馈调节缺失所致。总之,PSC 中的慢性胆汁淤积诱导肠内 BA 转运体和 FXR 的表达适应性改变。然而,在慢性胆汁淤积中预期的 CYP7A1 下调和 CYP3A4 上调可能会促进 PSC 中的 BA 诱导的肝损伤。

相似文献

1
Impaired Hepatic Adaptation to Chronic Cholestasis induced by Primary Sclerosing Cholangitis.原发性硬化性胆管炎引起的慢性胆汁淤积导致的肝适应性受损。
Sci Rep. 2016 Dec 23;6:39573. doi: 10.1038/srep39573.
2
Loss of apical sodium bile acid transporter alters bile acid circulation and reduces biliary damage in cholangitis.顶端钠胆酸转运蛋白缺失改变胆酸循环,减少胆管炎中的胆汁损害。
Am J Physiol Gastrointest Liver Physiol. 2023 Jan 1;324(1):G60-G77. doi: 10.1152/ajpgi.00112.2022. Epub 2022 Nov 21.
3
Targeting FXR in Cholestasis.胆汁淤积症中靶向法尼醇X受体
Handb Exp Pharmacol. 2019;256:299-324. doi: 10.1007/164_2019_231.
4
Selective activation of nuclear bile acid receptor FXR in the intestine protects mice against cholestasis.肠道中核胆汁酸受体 FXR 的选择性激活可保护小鼠免受胆汁淤积。
Gastroenterology. 2012 Feb;142(2):355-65.e1-4. doi: 10.1053/j.gastro.2011.10.028. Epub 2011 Nov 2.
5
Impaired Intestinal Farnesoid X Receptor Signaling in Cystic Fibrosis Mice.囊性纤维化小鼠肠道法尼醇 X 受体信号转导受损。
Cell Mol Gastroenterol Hepatol. 2020;9(1):47-60. doi: 10.1016/j.jcmgh.2019.08.006. Epub 2019 Aug 27.
6
FXR agonist GW4064 improves liver and intestinal pathology and alters bile acid metabolism in rats undergoing small intestinal resection.FXR 激动剂 GW4064 可改善小肠部分切除大鼠的肝脏和肠道病理,并改变胆汁酸代谢。
Am J Physiol Gastrointest Liver Physiol. 2019 Aug 1;317(2):G108-G115. doi: 10.1152/ajpgi.00356.2017. Epub 2019 Mar 28.
7
Fibroblast Growth Factor 21 Response in a Preclinical Alcohol Model of Acute-on-Chronic Liver Injury.成纤维细胞生长因子21在慢性肝损伤急性发作临床前酒精模型中的反应
Int J Mol Sci. 2021 Jul 23;22(15):7898. doi: 10.3390/ijms22157898.
8
Dysregulated FXR-FGF19 signaling and choline metabolism are associated with gut dysbiosis and hyperplasia in a novel pig model of pediatric NASH.FXR-FGF19 信号失调和胆碱代谢与儿科 NASH 新型猪模型中的肠道菌群失调和增生有关。
Am J Physiol Gastrointest Liver Physiol. 2020 Mar 1;318(3):G582-G609. doi: 10.1152/ajpgi.00344.2019. Epub 2020 Jan 31.
9
Prolonged fibroblast growth factor 19 response in patients with primary sclerosing cholangitis after an oral chenodeoxycholic acid challenge.原发性硬化性胆管炎患者口服鹅去氧胆酸激发试验后成纤维细胞生长因子19的延长反应
Hepatol Int. 2017 Jan;11(1):132-140. doi: 10.1007/s12072-016-9769-7. Epub 2016 Sep 30.
10
Mast Cells Regulate Ductular Reaction and Intestinal Inflammation in Cholestasis Through Farnesoid X Receptor Signaling.肥大细胞通过法尼醇 X 受体信号调节胆汁淤积中的胆小管反应和肠道炎症。
Hepatology. 2021 Nov;74(5):2684-2698. doi: 10.1002/hep.32028. Epub 2021 Sep 9.

引用本文的文献

1
The Impact of Human Liver Transplantation on the Concentration of Fibroblast Growth Factors: FGF19 and FGF21.人类肝脏移植对成纤维细胞生长因子浓度的影响:FGF19和FGF21
Int J Mol Sci. 2025 Feb 3;26(3):1299. doi: 10.3390/ijms26031299.
2
Fecal deoxycholic acid associates with diet, intestinal microbes, and total bilirubin in primary sclerosing cholangitis.在原发性硬化性胆管炎中,粪便脱氧胆酸与饮食、肠道微生物及总胆红素相关。
JHEP Rep. 2024 Aug 22;6(12):101188. doi: 10.1016/j.jhepr.2024.101188. eCollection 2024 Dec.
3
Bile Acids-Based Therapies for Primary Sclerosing Cholangitis: Current Landscape and Future Developments.

本文引用的文献

1
Elevated interleukin-8 in bile of patients with primary sclerosing cholangitis.原发性硬化性胆管炎患者胆汁中白细胞介素-8升高。
Liver Int. 2016 Sep;36(9):1370-7. doi: 10.1111/liv.13092. Epub 2016 Mar 16.
2
Liver Expression of Sulphotransferase 2A1 Enzyme Is Impaired in Patients with Primary Sclerosing Cholangitis: Lack of the Response to Enhanced Expression of PXR.原发性硬化性胆管炎患者肝脏磺基转移酶 2A1 表达受损:缺乏对 PXR 增强表达的反应。
J Immunol Res. 2015;2015:571353. doi: 10.1155/2015/571353. Epub 2015 Oct 4.
3
Expression of hepatic Fibroblast Growth Factor 19 is enhanced in Primary Biliary Cirrhosis and correlates with severity of the disease.
基于胆汁酸的原发性硬化性胆管炎治疗方法:现状与未来发展。
Cells. 2024 Oct 4;13(19):1650. doi: 10.3390/cells13191650.
4
FXR-FGF19 signaling in the gut-liver axis is dysregulated in patients with cirrhosis and correlates with impaired intestinal defence.FXR-FGF19 信号在肝硬化患者的肠道-肝脏轴中失调,并与肠道防御功能受损相关。
Hepatol Int. 2024 Jun;18(3):929-942. doi: 10.1007/s12072-023-10636-4. Epub 2024 Feb 8.
5
Gut microbiota depletion aggravates bile acid-induced liver pathology in mice with a human-like bile acid composition.肠道微生物组耗竭加剧了具有人类样胆汁酸组成的小鼠中胆汁酸诱导的肝病理。
Clin Sci (Lond). 2023 Nov 15;137(21):1637-1650. doi: 10.1042/CS20230812.
6
Human Hepatocellular response in Cholestatic Liver Diseases.胆汁淤积性肝病的人肝细胞反应。
Organogenesis. 2023 Dec 31;19(1):2247576. doi: 10.1080/15476278.2023.2247576.
7
Primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD): a condition exemplifying the crosstalk of the gut-liver axis.原发性硬化性胆管炎 (PSC) 和炎症性肠病 (IBD):一种体现肠道-肝脏轴相互作用的病症。
Exp Mol Med. 2023 Jul;55(7):1380-1387. doi: 10.1038/s12276-023-01042-9. Epub 2023 Jul 18.
8
Bile Acids and Biliary Fibrosis.胆汁酸与胆汁性纤维化。
Cells. 2023 Mar 2;12(5):792. doi: 10.3390/cells12050792.
9
Altered Bioavailability and Pharmacokinetics in Crohn's Disease: Capturing Systems Parameters for PBPK to Assist with Predicting the Fate of Orally Administered Drugs.克罗恩病的生物利用度和药代动力学改变:捕获 PBPK 系统参数以帮助预测口服药物的命运。
Clin Pharmacokinet. 2022 Oct;61(10):1365-1392. doi: 10.1007/s40262-022-01169-4. Epub 2022 Sep 3.
10
Primary Sclerosing Cholangitis and Inflammatory Bowel Disease: A Review.原发性硬化性胆管炎与炎症性肠病:综述
J Clin Transl Hepatol. 2022 Jun 28;10(3):531-542. doi: 10.14218/JCTH.2021.00344. Epub 2022 Jan 20.
原发性胆汁性肝硬化中肝脏成纤维细胞生长因子19的表达增强,且与疾病严重程度相关。
Sci Rep. 2015 Aug 21;5:13462. doi: 10.1038/srep13462.
4
Hepatic expression of detoxification enzymes is decreased in human obstructive cholestasis due to gallstone biliary obstruction.由于胆结石性胆道梗阻导致的人类阻塞性胆汁淤积中,解毒酶的肝脏表达降低。
PLoS One. 2015 Mar 23;10(3):e0120055. doi: 10.1371/journal.pone.0120055. eCollection 2015.
5
Loss of ileum decreases serum fibroblast growth factor 19 in relation to liver inflammation and fibrosis in pediatric onset intestinal failure.回肠丢失与儿童起病的肠衰竭相关的肝炎症和纤维化有关,降低血清成纤维细胞生长因子 19。
J Hepatol. 2015 Jun;62(6):1391-7. doi: 10.1016/j.jhep.2015.01.004. Epub 2015 Jan 13.
6
Serum metabolic signatures of primary biliary cirrhosis and primary sclerosing cholangitis.原发性胆汁性肝硬化和原发性硬化性胆管炎的血清代谢特征。
Liver Int. 2015 Jan;35(1):263-74. doi: 10.1111/liv.12680. Epub 2014 Sep 22.
7
Prospective evaluation of ursodeoxycholic acid withdrawal in patients with primary sclerosing cholangitis.原发性硬化性胆管炎患者熊去氧胆酸停药的前瞻性评估。
Hepatology. 2014 Sep;60(3):931-40. doi: 10.1002/hep.27074. Epub 2014 Jul 30.
8
c-Fos mediates repression of the apical sodium-dependent bile acid transporter by fibroblast growth factor-19 in mice.c-Fos 介导成纤维细胞生长因子 19 抑制小鼠顶膜钠依赖性胆汁酸转运体。
Am J Physiol Gastrointest Liver Physiol. 2014 Jan;306(2):G163-71. doi: 10.1152/ajpgi.00276.2013. Epub 2013 Dec 5.
9
Primary sclerosing cholangitis.原发性硬化性胆管炎。
Lancet. 2013 Nov 9;382(9904):1587-99. doi: 10.1016/S0140-6736(13)60096-3. Epub 2013 Jun 28.
10
Nuclear receptors HNF4α and LRH-1 cooperate in regulating Cyp7a1 in vivo.核受体 HNF4α 和 LRH-1 在内体中合作调节 Cyp7a1。
J Biol Chem. 2012 Nov 30;287(49):41334-41. doi: 10.1074/jbc.M112.421834. Epub 2012 Oct 4.